BMY in the 13F filings
Bristol-myers Squibb Co · CUSIP 110122108
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 11 Feb 2025
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 23 listed it in both
- Shares listed
- 117,190,989
- combined, among listed positions
- Reported value
- $6.6bn
- combined, at the quarter end
Among the 94 comparable managers: 14 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing BMY in Q4 2024
27 of 27 holders
What managers have written about BMY
Shown because the letter names the company. A letter is commentary; it is not a record of why a position changed.
- Starboard's February 2019 letter to Bristol-Myers Squibb shareholders on the Celgene deal28 Feb 2019 · Activist letter · Subject of the letter · Starboard Value LP’s 13F
- Before the letter
- 31 Dec 2018 (Q4 2018 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.
- After the letter
- 31 Mar 2019 (Q1 2019 13F): not among Starboard Value LP’s listed positions. A holding below the listed range, under another security, or none at all would read the same.
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 8,482,363 shares now+3,296,928
- Farallon Capital Management LLCnew position · 3,188,000 shares now+3,188,000
- Bridgewater Associates LPexisting position · 2,061,076 shares now+1,450,718
- Neuberger Berman Group LLCexisting position · 2,650,872 shares now+849,460
- Woodline Partners LPexisting position · 1,561,622 shares now+783,466
Reductions
- Fidelity (FMR LLC)existing position · 31,110,819 shares now-13,829,790
- T. Rowe Price Associates Incexisting position · 7,527,911 shares now-12,711,872
- Two Sigma Advisers LPexisting position · 1,857,900 shares now-7,692,600
- Man Group PLCexisting position · 1,728,127 shares now-1,501,885
- Point72 Asset Management LPexisting position · 1,410,278 shares now-1,470,027
New positions and exits
New (2)
Exited (2)
- Marshall Wace LLPwas $45m
- Moore Capital Management LPwas $2.2m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $12.2bn | n.a. | n.a. |
| Q3 2013 | 24 | $13.4bn | n.a. | n.a. |
| Q4 2013 | 23 | $14.8bn | n.a. | n.a. |
| Q1 2014 | 26 | $14.9bn | n.a. | n.a. |
| Q2 2014 | 25 | $14.7bn | n.a. | n.a. |
| Q3 2014 | 24 | $15.8bn | n.a. | n.a. |
| Q4 2014 | 21 | $18.3bn | n.a. | n.a. |
| Q1 2015 | 29 | $20.3bn | n.a. | n.a. |
| Q2 2015 | 24 | $21.7bn | n.a. | n.a. |
| Q3 2015 | 29 | $19.9bn | n.a. | n.a. |
| Q4 2015 | 29 | $22.5bn | n.a. | n.a. |
| Q1 2016 | 27 | $21.3bn | n.a. | n.a. |
| Q2 2016 | 31 | $24.0bn | n.a. | n.a. |
| Q3 2016 | 33 | $16.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $20.1bn | n.a. | n.a. |
| Q1 2017 | 36 | $17.9bn | n.a. | n.a. |
| Q2 2017 | 36 | $17.8bn | n.a. | n.a. |
| Q3 2017 | 34 | $20.2bn | n.a. | n.a. |
| Q4 2017 | 35 | $19.0bn | n.a. | n.a. |
| Q1 2018 | 32 | $19.3bn | n.a. | n.a. |
| Q2 2018 | 33 | $18.0bn | n.a. | n.a. |
| Q3 2018 | 35 | $19.9bn | n.a. | n.a. |
| Q4 2018 | 36 | $16.6bn | n.a. | n.a. |
| Q1 2019 | 44 | $16.9bn | n.a. | n.a. |
| Q2 2019 | 31 | $16.8bn | n.a. | n.a. |
| Q3 2019 | 31 | $18.0bn | n.a. | n.a. |
| Q4 2019 | 29 | $24.1bn | n.a. | n.a. |
| Q1 2020 | 29 | $18.9bn | n.a. | n.a. |
| Q2 2020 | 35 | $18.0bn | n.a. | n.a. |
| Q3 2020 | 31 | $18.8bn | n.a. | n.a. |
| Q4 2020 | 28 | $16.4bn | n.a. | n.a. |
| Q1 2021 | 31 | $15.2bn | n.a. | n.a. |
| Q2 2021 | 27 | $16.3bn | n.a. | n.a. |
| Q3 2021 | 30 | $14.2bn | n.a. | n.a. |
| Q4 2021 | 28 | $12.9bn | n.a. | n.a. |
| Q1 2022 | 28 | $15.2bn | n.a. | n.a. |
| Q2 2022 | 31 | $14.8bn | n.a. | n.a. |
| Q3 2022 | 27 | $12.2bn | n.a. | n.a. |
| Q4 2022 | 33 | $10.0bn | n.a. | n.a. |
| Q1 2023 | 29 | $8.4bn | n.a. | n.a. |
| Q2 2023 | 29 | $7.9bn | n.a. | n.a. |
| Q3 2023 | 32 | $7.5bn | n.a. | n.a. |
| Q4 2023 | 30 | $7.2bn | 19 | 12 |
| Q1 2024 | 20 | $6.6bn | 12 | 10 |
| Q2 2024 | 26 | $6.4bn | 17 | 10 |
| Q3 2024 | 31 | $7.9bn | 18 | 13 |
| Q4 2024 | 27 | $6.6bn | 14 | 13 |
| Q1 2025 | 20 | $6.6bn | 9 | 13 |
| Q2 2025 | 22 | $5.6bn | 16 | 8 |
| Q3 2025 | 28 | $5.4bn | 19 | 9 |
| Q4 2025 | 25 | $7.7bn | 13 | 27 |
| Q1 2026 | 27 | $8.3bn | 17 | 22 |
| Q2 2026 | 22 | $8.2bn | 15 | 23 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BMY and LLY →BMY and JNJ →BMY and VRTX →Choose a stock to compare with BMY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BMY, latest filings →Back to the 13F Explorer →